| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | TEVA PHARMACEUTICAL INDS LTD | 1,750,000 | 103,425,000 | 7.04% | ||
| 2 | SPDR S&P 500 ETF TR | 500,000 | 102,925,000 | 7.01% | Put | |
| 3 | ASTRAZENECA PLC | 1,250,000 | 79,638,000 | 5.42% | ||
| 4 | SELECT SECTOR SPDR TR | 1,000,000 | 74,390,000 | 5.06% | Put | |
| 5 | MASIMO CORP COM | 1,900,000 | 73,606,000 | 5.01% | ||
| 6 | MEDICINES CO | 2,500,000 | 71,525,000 | 4.87% | ||
| 7 | EXPRESS SCRIPTS HLDG CO | 750,000 | 66,705,000 | 4.54% | ||
| 8 | LIVANOVA PLC | 1,000,000 | 59,460,000 | 4.05% | ||
| 9 | GENOMIC HEALTH INC COM | 2,100,000 | 58,359,000 | 3.97% | ||
| 10 | SELECT MED HLDGS CORP COM | 3,500,000 | 56,700,000 | 3.86% | ||
| 11 | UNIVERSAL AMERN CORP NEW | 5,234,898 | 52,977,000 | 3.61% | ||
| 12 | NUVASIVE INC COM | 1,100,000 | 52,118,000 | 3.55% | ||
| 13 | ORTHOFIX INTERNATIONAL NV | 1,500,000 | 49,680,000 | 3.38% | ||
| 14 | JOHNSON & JOHNSON | 500,000 | 48,730,000 | 3.32% | Call | |
| 15 | CIGNA CORPORATION | 300,000 | 48,600,000 | 3.31% | ||
| 16 | LABORATORY CORP AMER HLDGS | 400,000 | 48,488,000 | 3.30% | ||
| 17 | ARIAD PHARMACEUTICALS INC | 5,750,000 | 47,553,000 | 3.24% | ||
| 18 | ARENA PHARMACEUTICALS INC | 7,500,000 | 34,800,000 | 2.37% | ||
| 19 | SEQUENOM INC | 9,000,000 | 27,360,000 | 1.86% | ||
| 20 | Dentsply Intl Inc | 500,000 | 25,775,000 | 1.75% | ||
| 21 | AMARIN CORP PLC | 10,000,000 | 24,600,000 | 1.67% | ||
| 22 | PERRIGO CO PLC | 122,748 | 22,688,000 | 1.54% | ||
| 23 | KINDRED HEALTHCARE INC | 1,100,000 | 22,319,000 | 1.52% | ||
| 24 | CROSS CTRY HEALTHCARE INC COM | 1,493,765 | 18,941,000 | 1.29% | ||
| 25 | NEKTAR THERAPEUTICS COM | 1,500,000 | 18,765,000 | 1.28% | ||
| 26 | QUEST DIAGNOSTICS INC | 250,000 | 18,130,000 | 1.23% | ||
| 27 | BIOSCRIP INC | 4,650,000 | 16,880,000 | 1.15% | ||
| 28 | INNOCOLL AG | 1,111,111 | 16,344,000 | 1.11% | ||
| 29 | PROTALIX BIOTHERAPEUTICS INC | 7,274,577 | 14,185,000 | 0.97% | ||
| 30 | VERACYTE INC | 1,226,994 | 13,669,000 | 0.93% | ||
| 31 | ANGIODYNAMICS INC | 735,383 | 12,060,000 | 0.82% | ||
| 32 | DURECT CORP | 5,000,000 | 11,950,000 | 0.81% | ||
| 33 | Catabasis Pharmaceuticals Inc | 927,609 | 11,326,000 | 0.77% | ||
| 34 | EPIRUS BIOPHARMA | 1,847,500 | 10,549,000 | 0.72% | ||
| 35 | BIOLASE INC | 5,332,394 | 9,278,000 | 0.63% | ||
| 36 | GENMARK DIAGNOSTICS INC COM | 1,017,897 | 9,222,000 | 0.63% | ||
| 37 | INVITAE CORP | 500,000 | 7,440,000 | 0.51% | ||
| 38 | ORASURE TECHNOLOGIES INC | 1,299,475 | 7,004,000 | 0.48% | ||
| 39 | PROTALIX BIOTHERAPEUTICS INC | 9,000,000 | 6,960,000 | 0.47% | PRN | |
| 40 | KERYX BIOPHARMACEUTICALS INCORPORATED | 500,000 | 4,990,000 | 0.34% | ||
| 41 | TARGACEPT INC | 1,560,000 | 4,352,000 | 0.30% | ||
| 42 | CARDICA INC | 8,374,846 | 4,179,000 | 0.28% | ||
| 43 | BIOLASE INC | 1,841,173 | 82,000 | 0.01% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001546927-15-000225, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
